The ETF headlines in May were ruled by the reopening of economies, hopes for a COVID-19 vaccine and global economic stimulus.
These ETF areas skyrocketed in May and easily beat the broader market.
Inside the best performing stocks in the top cannabis ETF of May.
Cannabis stocks and ETFs jumped last week. Here's why.
"Essential Business" status tagged with marijuana selling amid lockdowns should have helped cannabis stocks and ETFs in the first quarter.
These ETF areas outperformed the broader market gains last week.
After a historic crash due to the coronavirus pandemic, the Wall Street staged a solid rebound last week on the largest fiscal stimulus in history.
Marijuana companies are witnessing robust demand amid the coronavirus outbreak. Time to buy some earlier-battered marijuana stocks and ETFs?
Solid earnings drive Canopy Growth stock and boost the industry as a result. Is it right time to buy marijuana ETFs?
The year 2020 has so far been marked with Middle East tensions, the coronavirus outbreak and Wall Street rally. These sector ETFs have come across as winners and losers.
We have highlighted ETFs from the best and worst zones to start 2020.
Inside the ETF areas that were winners last week.
We have presented a bunch of top-performing ETFs to start 2020 that are likely to continue outperforming, should the trends prevail.
With a greater legislative push to legalize recreational marijuana, cannabis ETFs are soaring to start the year and are likely to continue doing so.
Inside the top and worst-performing ETFs of the fourth quarter.
Marijuana ETFs hit a high in 2018 only to experience a bloodbath in 2019. Let's see what lies in store for the space in 2020.
Wall Street continued its uptrend last week with the S&P 500 and Nasdaq hitting new highs, climbing 0.7% and 0.9%, respectively.
Inside the key ETF events of the month of November.
November was kind to the stock market with major bourses logging the best monthly gain since June.